9-cis-retinoic acid - Ontology Report

Help | FTP Download | Citing RGD | Contact Us

Keyword

ONTOLOGY REPORT - ANNOTATIONS

Term:	9-cis-retinoic acid	go back to main search page
Accession:	CHEBI:50648	browse the term
Definition:	A retinoic acid in which the exocyclic double bonds have 7E,9Z,11E,13E geometry.
Synonyms:	exact_synonym:	(9cis)-retinoic acid
	related_synonym:	(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; (7E,9Z,11E,13E)-retinoic acid; 9(Z)-Retinoic acid; 9-cis-Tretinoin; Alitretinoin; C20H28O2; CC(\\C=C\\C1=C(C)CCCC1(C)C)=C\\C=C\\C(C)=C\\C(O)=O; InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+; InChIKey=SHGAZHPCJJPHSC-ZVCIMWCZSA-N; Panretin; alitretinoina; alitretinoine; alitretinoinum
	alt_id:	CHEBI:63793
	xref_casrn:	5300-03-8
	xref:	ChEMBL:133216 "ChEMBL COMPOUND"; ChemIDplus:5300-03-8 "CAS Registry Number"; CiteXplore:10684759 "PubMed citation"; CiteXplore:11978340 "PubMed citation"; CiteXplore:12611604 "PubMed citation"; CiteXplore:12882648 "PubMed citation"; CiteXplore:15217968 "PubMed citation"; CiteXplore:15292987 "PubMed citation"; CiteXplore:15519497 "PubMed citation"; CiteXplore:16144296 "PubMed citation"; CiteXplore:17019405 "PubMed citation"; CiteXplore:18400206 "PubMed citation"; CiteXplore:18404486 "PubMed citation"; CiteXplore:19678713 "PubMed citation"; CiteXplore:7670094 "PubMed citation"; DrugBank:DB00523 "DrugBank"; HMDB:HMDB02369 "HMDB"; KEGG COMPOUND:C15493 "KEGG COMPOUND"; KEGG DRUG:D02815 "KEGG DRUG"; LIPID MAPS:LMPR01090022 "LIPID MAPS instance"
	xref_mesh:	MESH:C103303
	xref:	Reaxys:2057222 "Reaxys Registry Number"; Wikipedia:Alitretinoin "Wikipedia"

Rat
Mouse
Human
All
show annotations for term's descendants
Sort by:

9-cis-retinoic acid
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1		multiple interactions	EXP	9	107,543,283	107,690,527	RGD:6480464	CTD
G	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3		increases expression	ISO	17	48,712,218	48,769,063	RGD:6480464	CTD
G	ABCC6	ATP-binding cassette, sub-family C (CFTR/MRP), member 6		increases expression	EXP	16	16,243,422	16,317,328	RGD:6480464	CTD
G	ABCC6	ATP-binding cassette, sub-family C (CFTR/MRP), member 6		multiple interactions	EXP	16	16,243,422	16,317,328	RGD:6480464	CTD
G	ABCD3	ATP-binding cassette, sub-family D (ALD), member 3		increases expression	ISO	1	94,883,933	94,984,219	RGD:6480464	CTD
G	ABCG1	ATP-binding cassette, sub-family G (WHITE), member 1		increases expression	EXP	21	43,619,799	43,717,354	RGD:6480464	CTD
G	ABCG1	ATP-binding cassette, sub-family G (WHITE), member 1		multiple interactions	EXP	21	43,619,799	43,717,354	RGD:6480464	CTD
G	ABCG1	ATP-binding cassette, sub-family G (WHITE), member 1		increases expression	ISO	21	43,619,799	43,717,354	RGD:6480464	CTD
G	ABCG1	ATP-binding cassette, sub-family G (WHITE), member 1		multiple interactions	ISO	21	43,619,799	43,717,354	RGD:6480464	CTD
G	ACOT2	acyl-CoA thioesterase 2		increases expression	ISO	14	74,034,324	74,042,362	RGD:6480464	CTD
G	ACTA2	actin, alpha 2, smooth muscle, aorta		multiple interactions	ISO	10	90,694,831	90,751,147	RGD:6480464	CTD
G	ACTA2	actin, alpha 2, smooth muscle, aorta		increases expression	ISO	10	90,694,831	90,751,147	RGD:6480464	CTD
G	ACTA2	actin, alpha 2, smooth muscle, aorta		increases expression	ISO	10	90,694,831	90,751,147	RGD:6480464	CTD
G	ACTA2	actin, alpha 2, smooth muscle, aorta		multiple interactions	ISO	10	90,694,831	90,751,147	RGD:6480464	CTD
G	ACTG2	actin, gamma 2, smooth muscle, enteric		decreases expression	ISO	2	74,120,093	74,146,780	RGD:6480464	CTD
G	ADIPOR1	adiponectin receptor 1		multiple interactions	EXP	1	202,909,960	202,927,700	RGD:6480464	CTD
G	AHSG	alpha-2-HS-glycoprotein		decreases expression	ISO	3	186,330,850	186,339,107	RGD:6480464	CTD
G	AIP	aryl hydrocarbon receptor interacting protein		decreases expression	EXP	11	67,250,505	67,258,579	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		increases phosphorylation	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		decreases phosphorylation	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		decreases phosphorylation	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		increases phosphorylation	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	APP	amyloid beta (A4) precursor protein		multiple interactions	EXP	21	27,252,861	27,543,446	RGD:6480464	CTD
G	ARPC1B	actin related protein 2/3 complex, subunit 1B, 41kDa		increases expression	ISO	7	98,972,298	98,992,424	RGD:6480464	CTD
G	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide		decreases expression	ISO	1	169,075,947	169,101,960	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases response to substance	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2L11	BCL2-like 11 (apoptosis facilitator)		multiple interactions	EXP	2	111,878,491	111,926,022	RGD:6480464	CTD
G	BCL2L11	BCL2-like 11 (apoptosis facilitator)		increases expression	EXP	2	111,878,491	111,926,022	RGD:6480464	CTD
G	BCMO1	beta-carotene 15,15'-monooxygenase 1		decreases expression	ISO	16	81,272,296	81,324,747	RGD:6480464	CTD
G	BGLAP	bone gamma-carboxyglutamate (gla) protein		decreases expression	ISO	1	156,211,951	156,213,123	RGD:6480464	CTD
G	BGLAP	bone gamma-carboxyglutamate (gla) protein		decreases expression	ISO	1	156,211,951	156,213,123	RGD:6480464	CTD
G	BGLAP	bone gamma-carboxyglutamate (gla) protein		multiple interactions	EXP	1	156,211,951	156,213,123	RGD:6480464	CTD
G	BGLAP	bone gamma-carboxyglutamate (gla) protein		decreases expression	EXP	1	156,211,951	156,213,123	RGD:6480464	CTD
G	BGLAP	bone gamma-carboxyglutamate (gla) protein		decreases expression	ISO	1	156,211,951	156,213,123	RGD:6480464	CTD
G	CA2	carbonic anhydrase II		multiple interactions	EXP	8	86,376,131	86,393,721	RGD:6480464	CTD
G	CA2	carbonic anhydrase II		increases expression	EXP	8	86,376,131	86,393,721	RGD:6480464	CTD
G	CAMK2G	calcium/calmodulin-dependent protein kinase II gamma		increases expression	ISO	10	75,572,259	75,634,349	RGD:6480464	CTD
G	CAMK4	calcium/calmodulin-dependent protein kinase IV		multiple interactions	ISO	5	110,559,947	110,820,749	RGD:6480464	CTD
G	CAPN1	calpain 1, (mu/I) large subunit		decreases expression	ISO	11	64,948,686	64,979,477	RGD:6480464	CTD
G	CAPN2	calpain 2, (m/II) large subunit		decreases expression	ISO	1	223,889,295	223,963,720	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases expression	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases expression	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP7	caspase 7, apoptosis-related cysteine peptidase		multiple interactions	ISO	10	115,438,921	115,490,668	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		increases activity	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CBX3	chromobox homolog 3		decreases expression	EXP	7	26,240,831	26,253,227	RGD:6480464	CTD
G	CCL2	chemokine (C-C motif) ligand 2		multiple interactions	EXP	17	32,582,296	32,584,222	RGD:6480464	CTD
G	CCND3	cyclin D3		decreases expression	EXP	6	41,902,671	42,016,610	RGD:6480464	CTD
G	CCR2	chemokine (C-C motif) receptor 2		multiple interactions	EXP	3	46,395,235	46,402,413	RGD:6480464	CTD
G	CCR2	chemokine (C-C motif) receptor 2		decreases expression	EXP	3	46,395,235	46,402,413	RGD:6480464	CTD
G	CCR3	chemokine (C-C motif) receptor 3		increases expression	EXP	3	46,283,872	46,308,197	RGD:6480464	CTD
G	CCR7	chemokine (C-C motif) receptor 7		decreases expression	EXP	17	38,710,021	38,721,736	RGD:6480464	CTD
G	CCR7	chemokine (C-C motif) receptor 7		increases expression	EXP	17	38,710,021	38,721,736	RGD:6480464	CTD
G	CD1A	CD1a molecule		multiple interactions	EXP	1	158,223,927	158,228,059	RGD:6480464	CTD
G	CD1A	CD1a molecule		decreases expression	EXP	1	158,223,927	158,228,059	RGD:6480464	CTD
G	CD36	CD36 molecule (thrombospondin receptor)		multiple interactions	EXP	7	80,231,504	80,308,593	RGD:6480464	CTD
G	CD36	CD36 molecule (thrombospondin receptor)		decreases expression	EXP	7	80,231,504	80,308,593	RGD:6480464	CTD
G	CD37	CD37 molecule		increases expression	ISO	19	49,838,677	49,843,863	RGD:6480464	CTD
G	CD38	CD38 molecule		increases expression	EXP	4	15,779,931	15,850,706	RGD:6480464	CTD
G	CD38	CD38 molecule		multiple interactions	EXP	4	15,779,931	15,850,706	RGD:6480464	CTD
G	CD38	CD38 molecule		increases expression	EXP	4	15,779,931	15,850,706	RGD:6480464	CTD
G	CD38	CD38 molecule		increases expression	EXP	4	15,779,931	15,850,706	RGD:6480464	CTD
G	CD80	CD80 molecule		multiple interactions	EXP	3	119,243,140	119,278,481	RGD:6480464	CTD
G	CD80	CD80 molecule		decreases expression	EXP	3	119,243,140	119,278,481	RGD:6480464	CTD
G	CD83	CD83 molecule		increases expression	EXP	6	14,117,487	14,137,149	RGD:6480464	CTD
G	CD86	CD86 molecule		multiple interactions	EXP	3	121,774,209	121,839,990	RGD:6480464	CTD
G	CD86	CD86 molecule		increases expression	EXP	3	121,774,209	121,839,990	RGD:6480464	CTD
G	CDH1	cadherin 1, type 1, E-cadherin (epithelial)		affects expression	EXP	16	68,771,195	68,869,444	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		decreases expression	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		multiple interactions	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		increases expression	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1C	cyclin-dependent kinase inhibitor 1C (p57, Kip2)		decreases expression	EXP	11	2,904,448	2,906,995	RGD:6480464	CTD
G	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta		multiple interactions	ISO	20	48,807,120	48,809,227	RGD:6480464	CTD
G	CETP	cholesteryl ester transfer protein, plasma		multiple interactions	EXP	16	56,995,835	57,017,756	RGD:6480464	CTD
G	CETP	cholesteryl ester transfer protein, plasma		increases expression	EXP	16	56,995,835	57,017,756	RGD:6480464	CTD
G	CGB	chorionic gonadotropin, beta polypeptide		increases expression	EXP	19	49,526,126	49,527,632	RGD:6480464	CTD
G	CIAO1	cytosolic iron-sulfur protein assembly 1		decreases expression	ISO	2	96,931,884	96,939,917	RGD:6480464	CTD
G	CIITA	class II, major histocompatibility complex, transactivator		increases expression	EXP	16	10,971,055	11,018,840	RGD:6480464	CTD
G	CNN1	calponin 1, basic, smooth muscle		increases expression	ISO	19	11,649,579	11,661,138	RGD:6480464	CTD
G	CNN1	calponin 1, basic, smooth muscle		multiple interactions	ISO	19	11,649,579	11,661,138	RGD:6480464	CTD
G	COL12A1	collagen, type XII, alpha 1		decreases expression	ISO	6	75,794,042	75,915,623	RGD:6480464	CTD
G	COL17A1	collagen, type XVII, alpha 1		decreases expression	EXP	10	105,791,046	105,845,638	RGD:6480464	CTD
G	COL1A1	collagen, type I, alpha 1		increases expression	EXP	17	48,261,457	48,279,000	RGD:6480464	CTD
G	COL1A2	collagen, type I, alpha 2		increases expression	ISO	7	94,023,873	94,060,544	RGD:6480464	CTD
G	COL4A2	collagen, type IV, alpha 2		increases expression	EXP	13	110,959,631	111,165,374	RGD:6480464	CTD
G	COL6A1	collagen, type VI, alpha 1		decreases expression	EXP	21	47,401,663	47,424,963	RGD:6480464	CTD
G	COL8A2	collagen, type VIII, alpha 2		increases expression	EXP	1	36,560,842	36,565,850	RGD:6480464	CTD
G	CORO1B	coronin, actin binding protein, 1B		increases expression	ISO	11	67,205,518	67,211,292	RGD:6480464	CTD
G	CRABP1	cellular retinoic acid binding protein 1		decreases response to substance	EXP	15	78,632,666	78,640,572	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		increases expression	ISO	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		increases expression	EXP	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		increases expression	ISO	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		increases expression	EXP	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CREB1	cAMP responsive element binding protein 1		increases phosphorylation	EXP	2	208,394,616	208,470,284	RGD:6480464	CTD
G	CROT	carnitine O-octanoyltransferase		increases expression	ISO	7	86,974,951	87,029,112	RGD:6480464	CTD
G	CXCL1	chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)		decreases expression	EXP	4	74,735,109	74,737,019	RGD:6480464	CTD
G	CXCL14	chemokine (C-X-C motif) ligand 14		decreases expression	ISO	5	134,906,369	134,914,969	RGD:6480464	CTD
G	CYP19A1	cytochrome P450, family 19, subfamily A, polypeptide 1		multiple interactions	EXP	15	51,500,254	51,630,795	RGD:6480464	CTD
G	CYP19A1	cytochrome P450, family 19, subfamily A, polypeptide 1		multiple interactions	EXP	15	51,500,254	51,630,795	RGD:6480464	CTD
G	CYP19A1	cytochrome P450, family 19, subfamily A, polypeptide 1		increases expression	EXP	15	51,500,254	51,630,795	RGD:6480464	CTD
G	CYP26A1	cytochrome P450, family 26, subfamily A, polypeptide 1		increases expression	EXP	10	94,833,232	94,837,641	RGD:6480464	CTD
G	CYP26A1	cytochrome P450, family 26, subfamily A, polypeptide 1		increases expression	ISO	10	94,833,232	94,837,641	RGD:6480464	CTD
G	CYP27A1	cytochrome P450, family 27, subfamily A, polypeptide 1		decreases expression	EXP	2	219,646,472	219,680,016	RGD:6480464	CTD
G	CYP27A1	cytochrome P450, family 27, subfamily A, polypeptide 1		increases expression	EXP	2	219,646,472	219,680,016	RGD:6480464	CTD
G	CYP27A1	cytochrome P450, family 27, subfamily A, polypeptide 1		multiple interactions	EXP	2	219,646,472	219,680,016	RGD:6480464	CTD
G	CYP3A4	cytochrome P450, family 3, subfamily A, polypeptide 4		multiple interactions	EXP	7	99,354,583	99,381,811	RGD:6480464	CTD
G	CYP3A4	cytochrome P450, family 3, subfamily A, polypeptide 4		increases activity	EXP	7	99,354,583	99,381,811	RGD:6480464	CTD
G	CYP3A4	cytochrome P450, family 3, subfamily A, polypeptide 4		multiple interactions	EXP	7	99,354,583	99,381,811	RGD:6480464	CTD
G	CYP3A7	cytochrome P450, family 3, subfamily A, polypeptide 7		decreases expression	EXP	7	99,302,660	99,332,819	RGD:6480464	CTD
G	DHRS9	dehydrogenase/reductase (SDR family) member 9		increases expression	EXP	2	169,921,299	169,952,677	RGD:6480464	CTD
G	DIO3	deiodinase, iodothyronine, type III		increases activity	EXP	14	102,027,688	102,029,789	RGD:6480464	CTD
G	DNAJA1	DnaJ (Hsp40) homolog, subfamily A, member 1		decreases expression	ISO	9	33,025,209	33,039,062	RGD:6480464	CTD
G	DSC1	desmocollin 1		decreases expression	EXP	18	28,709,199	28,742,819	RGD:6480464	CTD
G	DUSP10	dual specificity phosphatase 10		increases expression	EXP	1	221,874,764	221,915,516	RGD:6480464	CTD
G	DUSP11	dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)		decreases expression	EXP	2	73,989,325	74,007,284	RGD:6480464	CTD
G	EGFR	epidermal growth factor receptor		decreases expression	EXP	7	55,086,725	55,275,031	RGD:6480464	CTD
G	EIF4EBP2	eukaryotic translation initiation factor 4E binding protein 2		decreases expression	EXP	10	72,163,861	72,188,374	RGD:6480464	CTD
G	EMP1	epithelial membrane protein 1		increases expression	EXP	12	13,349,602	13,369,708	RGD:6480464	CTD
G	ESR1	estrogen receptor 1		decreases expression	ISO	6	152,011,631	152,424,409	RGD:6480464	CTD
G	ESR1	estrogen receptor 1		multiple interactions	ISO	6	152,011,631	152,424,409	RGD:6480464	CTD
G	ESR1	estrogen receptor 1		multiple interactions	EXP	6	152,011,631	152,424,409	RGD:6480464	CTD
G	ESR2	estrogen receptor 2 (ER beta)		multiple interactions	EXP	14	64,693,751	64,805,268	RGD:6480464	CTD
G	FABP5	fatty acid binding protein 5 (psoriasis-associated)		decreases expression	EXP	8	82,192,718	82,197,012	RGD:6480464	CTD
G	FAM3C	family with sequence similarity 3, member C		increases expression	EXP	7	120,988,905	121,036,422	RGD:6480464	CTD
G	FAS	Fas (TNF receptor superfamily, member 6)		decreases expression	EXP	10	90,750,288	90,775,542	RGD:6480464	CTD
G	FAS	Fas (TNF receptor superfamily, member 6)		increases expression	EXP	10	90,750,288	90,775,542	RGD:6480464	CTD
G	FASN	fatty acid synthase		decreases expression	EXP	17	80,036,214	80,056,106	RGD:6480464	CTD
G	FASTK	Fas-activated serine/threonine kinase		decreases expression	EXP	7	150,773,708	150,777,970	RGD:6480464	CTD
G	FDFT1	farnesyl-diphosphate farnesyltransferase 1		increases expression	ISO	8	11,660,190	11,696,818	RGD:6480464	CTD
G	FGF1	fibroblast growth factor 1 (acidic)		decreases expression	EXP	5	141,971,743	142,077,635	RGD:6480464	CTD
G	FHL1	four and a half LIM domains 1		multiple interactions	ISO	X	135,228,861	135,293,518	RGD:6480464	CTD
G	FHL1	four and a half LIM domains 1		increases expression	ISO	X	135,228,861	135,293,518	RGD:6480464	CTD
G	FLG	filaggrin		decreases expression	EXP	1	152,274,651	152,297,679	RGD:6480464	CTD
G	FN1	fibronectin 1		decreases expression	EXP	2	216,225,177	216,300,791	RGD:6480464	CTD
G	FN1	fibronectin 1		increases expression	ISO	2	216,225,177	216,300,791	RGD:6480464	CTD
G	FOXA1	forkhead box A1		increases expression	EXP	14	38,058,757	38,064,325	RGD:6480464	CTD
G	G6PD	glucose-6-phosphate dehydrogenase		increases expression	EXP	X	153,759,606	153,775,787	RGD:6480464	CTD
G	GATA6	GATA binding protein 6		increases expression	EXP	18	19,749,404	19,782,491	RGD:6480464	CTD
G	GBA	glucosidase, beta, acid		decreases expression	EXP	1	155,204,239	155,214,653	RGD:6480464	CTD
G	GCK	glucokinase (hexokinase 4)		decreases expression	ISO	7	44,183,870	44,229,022	RGD:6480464	CTD
G	GCK	glucokinase (hexokinase 4)		decreases activity	ISO	7	44,183,870	44,229,022	RGD:6480464	CTD
G	GDF15	growth differentiation factor 15		increases expression	EXP	19	18,496,968	18,499,986	RGD:6480464	CTD
G	GDF2	growth differentiation factor 2		decreases expression	EXP	10	48,413,092	48,416,853	RGD:6480464	CTD
G	GH1	growth hormone 1		increases expression	ISO	17	61,994,563	61,996,198	RGD:6480464	CTD
G	GH1	growth hormone 1		multiple interactions	ISO	17	61,994,563	61,996,198	RGD:6480464	CTD
G	GH1	growth hormone 1		increases expression	ISO	17	61,994,563	61,996,198	RGD:6480464	CTD
G	GH1	growth hormone 1		increases expression	ISO	17	61,994,563	61,996,198	RGD:6480464	CTD
G	GH1	growth hormone 1		increases expression	ISO	17	61,994,563	61,996,198	RGD:6480464	CTD
G	GHRH	growth hormone releasing hormone		multiple interactions	ISO	20	35,879,489	35,885,299	RGD:6480464	CTD
G	GLUL	glutamate-ammonia ligase		increases expression	EXP	1	182,350,839	182,361,341	RGD:6480464	CTD
G	GRB7	growth factor receptor-bound protein 7		decreases expression	EXP	17	37,894,162	37,903,538	RGD:6480464	CTD
G	GSTA2	glutathione S-transferase alpha 2		multiple interactions	ISO	6	52,614,885	52,628,361	RGD:6480464	CTD
G	GSTA2	glutathione S-transferase alpha 2		increases expression	ISO	6	52,614,885	52,628,361	RGD:6480464	CTD
G	GSTM1	glutathione S-transferase mu 1		decreases expression	EXP	1	110,230,418	110,236,367	RGD:6480464	CTD
G	HBEGF	heparin-binding EGF-like growth factor		increases expression	EXP	5	139,712,428	139,726,188	RGD:6480464	CTD
G	HGF	hepatocyte growth factor (hepapoietin A; scatter factor)		increases secretion	EXP	7	81,331,444	81,399,452	RGD:6480464	CTD
G	HGF	hepatocyte growth factor (hepapoietin A; scatter factor)		increases expression	EXP	7	81,331,444	81,399,452	RGD:6480464	CTD
G	HIST3H3	histone cluster 3, H3		multiple interactions	EXP	1	228,612,546	228,613,026	RGD:6480464	CTD
G	HIST4H4	histone cluster 4, H4		decreases expression	ISO	12	14,923,654	14,924,065	RGD:6480464	CTD
G	HIST4H4	histone cluster 4, H4		multiple interactions	EXP	12	14,923,654	14,924,065	RGD:6480464	CTD
G	HNF4A	hepatocyte nuclear factor 4, alpha		decreases expression	ISO	20	42,984,441	43,061,485	RGD:6480464	CTD
G	HPGDS	hematopoietic prostaglandin D synthase		increases expression	ISO	4	95,219,707	95,264,027	RGD:6480464	CTD
G	HSD11B1	hydroxysteroid (11-beta) dehydrogenase 1		decreases expression	EXP	1	209,859,525	209,908,295	RGD:6480464	CTD
G	HSD17B1	hydroxysteroid (17-beta) dehydrogenase 1		increases activity	EXP	17	40,703,984	40,707,232	RGD:6480464	CTD
G	HSD17B1	hydroxysteroid (17-beta) dehydrogenase 1		increases expression	EXP	17	40,703,984	40,707,232	RGD:6480464	CTD
G	HSPH1	heat shock 105kDa/110kDa protein 1		decreases expression	ISO	13	31,710,762	31,736,117	RGD:6480464	CTD
G	IFNG	interferon, gamma		decreases expression	EXP	12	68,548,550	68,553,521	RGD:6480464	CTD
G	IFNG	interferon, gamma		multiple interactions	EXP	12	68,548,550	68,553,521	RGD:6480464	CTD
G	IFNGR1	interferon gamma receptor 1		increases expression	EXP	6	137,518,621	137,540,567	RGD:6480464	CTD
G	IGF1	insulin-like growth factor 1 (somatomedin C)		increases expression	EXP	12	102,789,645	102,874,378	RGD:6480464	CTD
G	IGF1	insulin-like growth factor 1 (somatomedin C)		decreases expression	EXP	12	102,789,645	102,874,378	RGD:6480464	CTD
G	IGFBP2	insulin-like growth factor binding protein 2, 36kDa		increases expression	ISO	2	217,498,127	217,529,159	RGD:6480464	CTD
G	IGFBP3	insulin-like growth factor binding protein 3		affects binding	EXP	7	45,951,844	45,960,871	RGD:6480464	CTD
G	IGFBP3	insulin-like growth factor binding protein 3		increases expression	EXP	7	45,951,844	45,960,871	RGD:6480464	CTD
G	IGFBP3	insulin-like growth factor binding protein 3		increases expression	EXP	7	45,951,844	45,960,871	RGD:6480464	CTD
G	IL10RA	interleukin 10 receptor, alpha		decreases expression	EXP	11	117,857,106	117,872,198	RGD:6480464	CTD
G	IL12A	interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)		multiple interactions	EXP	3	159,706,623	159,713,806	RGD:6480464	CTD
G	IL12A	interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)		multiple interactions	EXP	3	159,706,623	159,713,806	RGD:6480464	CTD
G	IL12B	interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)		multiple interactions	EXP	5	158,741,791	158,757,481	RGD:6480464	CTD
G	IL12B	interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)		multiple interactions	EXP	5	158,741,791	158,757,481	RGD:6480464	CTD
G	IL12B	interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)		multiple interactions	ISO	5	158,741,791	158,757,481	RGD:6480464	CTD
G	IL13	interleukin 13		increases expression	EXP	5	131,993,865	131,996,801	RGD:6480464	CTD
G	IL1B	interleukin 1, beta		increases expression	EXP	2	113,587,337	113,594,356	RGD:6480464	CTD
G	IL1B	interleukin 1, beta		multiple interactions	ISO	2	113,587,337	113,594,356	RGD:6480464	CTD
G	IL1B	interleukin 1, beta		multiple interactions	ISO	2	113,587,337	113,594,356	RGD:6480464	CTD
G	IL2	interleukin 2		decreases expression	EXP	4	123,372,625	123,377,650	RGD:6480464	CTD
G	IL2	interleukin 2		multiple interactions	EXP	4	123,372,625	123,377,650	RGD:6480464	CTD
G	IL24	interleukin 24		decreases expression	EXP	1	207,070,788	207,077,484	RGD:6480464	CTD
G	IL4	interleukin 4		increases expression	EXP	5	132,009,678	132,018,370	RGD:6480464	CTD
G	IL5	interleukin 5 (colony-stimulating factor, eosinophil)		increases expression	EXP	5	131,877,136	131,879,214	RGD:6480464	CTD
G	IL6	interleukin 6 (interferon, beta 2)		multiple interactions	ISO	7	22,766,766	22,771,621	RGD:6480464	CTD
G	INSR	insulin receptor		increases phosphorylation	ISO	19	7,112,266	7,294,011	RGD:6480464	CTD
G	IRF1	interferon regulatory factor 1		increases expression	EXP	5	131,817,301	131,826,465	RGD:6480464	CTD
G	IRF1	interferon regulatory factor 1		increases expression	EXP	5	131,817,301	131,826,465	RGD:6480464	CTD
G	IRF1	interferon regulatory factor 1		increases expression	EXP	5	131,817,301	131,826,465	RGD:6480464	CTD
G	ITGA4	integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)		increases expression	EXP	2	182,321,619	182,402,474	RGD:6480464	CTD
G	ITGAM	integrin, alpha M (complement component 3 receptor 3 subunit)		multiple interactions	EXP	16	31,271,288	31,344,213	RGD:6480464	CTD
G	ITGAX	integrin, alpha X (complement component 3 receptor 4 subunit)		multiple interactions	EXP	16	31,366,509	31,394,318	RGD:6480464	CTD
G	ITGB2	integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)		multiple interactions	EXP	21	46,305,868	46,348,753	RGD:6480464	CTD
G	IVL	involucrin		increases expression	EXP	1	152,881,039	152,884,362	RGD:6480464	CTD
G	JUN	jun proto-oncogene		multiple interactions	EXP	1	59,246,463	59,249,785	RGD:6480464	CTD
G	KLF6	Kruppel-like factor 6		multiple interactions	ISO	10	3,818,188	3,827,473	RGD:6480464	CTD
G	KLK10	kallikrein-related peptidase 10		increases expression	EXP	19	51,516,000	51,523,431	RGD:6480464	CTD
G	KRT1	keratin 1		decreases expression	EXP	12	53,068,520	53,074,191	RGD:6480464	CTD
G	KRT10	keratin 10		decreases expression	EXP	17	38,974,369	38,978,863	RGD:6480464	CTD
G	KRT14	keratin 14		decreases expression	EXP	17	39,738,531	39,743,147	RGD:6480464	CTD
G	KRT15	keratin 15		increases expression	EXP	17	39,669,997	39,675,270	RGD:6480464	CTD
G	KRT17	keratin 17		decreases expression	EXP	17	39,775,692	39,780,882	RGD:6480464	CTD
G	KRT18	keratin 18		increases expression	EXP	12	53,342,655	53,346,685	RGD:6480464	CTD
G	KRT19	keratin 19		increases expression	EXP	17	39,679,869	39,684,641	RGD:6480464	CTD
G	KRT19	keratin 19		increases expression	EXP	17	39,679,869	39,684,641	RGD:6480464	CTD
G	KRT19	keratin 19		increases expression	EXP	17	39,679,869	39,684,641	RGD:6480464	CTD
G	KRT19	keratin 19		increases expression	EXP	17	39,679,869	39,684,641	RGD:6480464	CTD
G	KRT5	keratin 5		decreases expression	EXP	12	52,908,359	52,914,243	RGD:6480464	CTD
G	KRT6A	keratin 6A		decreases expression	EXP	12	52,880,958	52,887,181	RGD:6480464	CTD
G	KRT7	keratin 7		increases expression	EXP	12	52,626,954	52,642,709	RGD:6480464	CTD
G	KRT7	keratin 7		increases expression	EXP	12	52,626,954	52,642,709	RGD:6480464	CTD
G	KRT7	keratin 7		increases expression	EXP	12	52,626,954	52,642,709	RGD:6480464	CTD
G	KRT75	keratin 75		decreases expression	EXP	12	52,817,854	52,828,110	RGD:6480464	CTD
G	KRT8	keratin 8		increases expression	EXP	12	53,290,971	53,343,650	RGD:6480464	CTD
G	LAMA2	laminin, alpha 2		decreases expression	EXP	6	129,204,286	129,837,711	RGD:6480464	CTD
G	LAMA3	laminin, alpha 3		decreases expression	EXP	18	21,269,562	21,535,030	RGD:6480464	CTD
G	LAMC3	laminin, gamma 3		increases expression	EXP	9	133,884,504	133,968,446	RGD:6480464	CTD
G	LCN2	lipocalin 2		increases expression	EXP	9	130,911,732	130,915,734	RGD:6480464	CTD
G	LEP	leptin		multiple interactions	ISO	7	127,881,331	127,897,682	RGD:6480464	CTD
G	LPL	lipoprotein lipase		multiple interactions	EXP	8	19,796,582	19,824,770	RGD:6480464	CTD
G	LPL	lipoprotein lipase		increases expression	EXP	8	19,796,582	19,824,770	RGD:6480464	CTD
G	LYPLA1	lysophospholipase I		decreases expression	ISO	8	54,958,938	55,014,577	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		multiple interactions	ISO	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		multiple interactions	ISO	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK3	mitogen-activated protein kinase 3		multiple interactions	ISO	16	30,125,426	30,134,630	RGD:6480464	CTD
G	MAPK3	mitogen-activated protein kinase 3		multiple interactions	ISO	16	30,125,426	30,134,630	RGD:6480464	CTD
G	MARK1	MAP/microtubule affinity-regulating kinase 1		increases expression	ISO	1	220,701,568	220,837,799	RGD:6480464	CTD
G	MEIS1	Meis homeobox 1		increases expression	EXP	2	66,662,532	66,799,891	RGD:6480464	CTD
G	MEIS2	Meis homeobox 2		increases expression	EXP	15	37,183,222	37,393,500	RGD:6480464	CTD
G	MEOX1	mesenchyme homeobox 1		increases expression	EXP	17	41,717,757	41,739,262	RGD:6480464	CTD
G	MET	met proto-oncogene (hepatocyte growth factor receptor)		increases phosphorylation	EXP	7	116,312,459	116,438,440	RGD:6480464	CTD
G	MFAP2	microfibrillar-associated protein 2		decreases expression	EXP	1	17,300,997	17,308,081	RGD:6480464	CTD
G	MMP10	matrix metallopeptidase 10 (stromelysin 2)		decreases expression	EXP	11	102,641,233	102,651,359	RGD:6480464	CTD
G	MTOR	mechanistic target of rapamycin (serine/threonine kinase)		multiple interactions	ISO	1	11,166,588	11,322,608	RGD:6480464	CTD
G	MTTP	microsomal triglyceride transfer protein		increases expression	ISO	4	100,485,240	100,545,154	RGD:6480464	CTD
G	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming		increases expression	EXP	11	1,142,474	1,162,465	RGD:6480464	CTD
G	NCOA1	nuclear receptor coactivator 1		multiple interactions	EXP	2	24,807,346	24,993,571	RGD:6480464	CTD
G	NCOA1	nuclear receptor coactivator 1		multiple interactions	EXP	2	24,807,346	24,993,571	RGD:6480464	CTD
G	NDUFAF3	NADH dehydrogenase (ubiquinone) complex I, assembly factor 3		increases expression	ISO	3	49,057,908	49,060,928	RGD:6480464	CTD
G	NEDD9	neural precursor cell expressed, developmentally down-regulated 9		increases expression	EXP	6	11,183,531	11,382,581	RGD:6480464	CTD
G	NEFL	neurofilament, light polypeptide		decreases expression	EXP	8	24,808,468	24,814,131	RGD:6480464	CTD
G	NEFM	neurofilament, medium polypeptide		increases expression	ISO	8	24,771,274	24,776,606	RGD:6480464	CTD
G	NFE2L2	nuclear factor (erythroid-derived 2)-like 2		multiple interactions	ISO	2	178,095,031	178,129,859	RGD:6480464	CTD
G	NKX3-1	NK3 homeobox 1		increases expression	EXP	8	23,536,206	23,540,450	RGD:6480464	CTD
G	NR1H2	nuclear receptor subfamily 1, group H, member 2		multiple interactions	EXP	19	50,879,680	50,886,285	RGD:6480464	CTD
G	NR1H3	nuclear receptor subfamily 1, group H, member 3		multiple interactions	EXP	11	47,269,851	47,290,584	RGD:6480464	CTD
G	NR1H3	nuclear receptor subfamily 1, group H, member 3		multiple interactions	EXP	11	47,269,851	47,290,584	RGD:6480464	CTD
G	NR1I2	nuclear receptor subfamily 1, group I, member 2		multiple interactions	EXP	3	119,499,331	119,537,332	RGD:6480464	CTD
G	NR1I3	nuclear receptor subfamily 1, group I, member 3		multiple interactions	EXP	1	161,199,456	161,208,000	RGD:6480464	CTD
G	NR1I3	nuclear receptor subfamily 1, group I, member 3		multiple interactions	ISO	1	161,199,456	161,208,000	RGD:6480464	CTD
G	NR1I3	nuclear receptor subfamily 1, group I, member 3		multiple interactions	EXP	1	161,199,456	161,208,000	RGD:6480464	CTD
G	NR5A2	nuclear receptor subfamily 5, group A, member 2		multiple interactions	EXP	1	199,996,770	200,146,552	RGD:6480464	CTD
G	NR5A2	nuclear receptor subfamily 5, group A, member 2		decreases expression	EXP	1	199,996,770	200,146,552	RGD:6480464	CTD
G	NRL	neural retina leucine zipper		increases expression	EXP	14	24,549,316	24,553,832	RGD:6480464	CTD
G	ODC1	ornithine decarboxylase 1		decreases expression	EXP	2	10,580,508	10,588,453	RGD:6480464	CTD
G	OLR1	oxidized low density lipoprotein (lectin-like) receptor 1		increases expression	EXP	12	10,310,899	10,324,790	RGD:6480464	CTD
G	P2RX2	purinergic receptor P2X, ligand-gated ion channel, 2		increases expression	ISO	12	133,195,403	133,198,972	RGD:6480464	CTD
G	PADI4	peptidyl arginine deiminase, type IV		increases expression	EXP	1	17,634,690	17,690,495	RGD:6480464	CTD
G	PADI4	peptidyl arginine deiminase, type IV		multiple interactions	EXP	1	17,634,690	17,690,495	RGD:6480464	CTD
G	PARP1	poly (ADP-ribose) polymerase 1		increases cleavage	EXP	1	226,548,392	226,595,801	RGD:6480464	CTD
G	PCK1	phosphoenolpyruvate carboxykinase 1 (soluble)		multiple interactions	ISO	20	56,136,137	56,141,513	RGD:6480464	CTD
G	PCK1	phosphoenolpyruvate carboxykinase 1 (soluble)		increases expression	ISO	20	56,136,137	56,141,513	RGD:6480464	CTD
G	PCSK2	proprotein convertase subtilisin/kexin type 2		increases expression	EXP	20	17,206,752	17,465,223	RGD:6480464	CTD
G	PDX1	pancreatic and duodenal homeobox 1		decreases expression	ISO	13	28,494,168	28,500,451	RGD:6480464	CTD
G	PDX1	pancreatic and duodenal homeobox 1		decreases expression	ISO	13	28,494,168	28,500,451	RGD:6480464	CTD
G	PER1	period circadian clock 1		increases expression	ISO	17	8,043,788	8,055,753	RGD:6480464	CTD
G	PEX19	peroxisomal biogenesis factor 19		decreases expression	ISO	1	160,246,599	160,254,941	RGD:6480464	CTD
G	PEX19	peroxisomal biogenesis factor 19		decreases expression	ISO	1	160,246,599	160,254,941	RGD:6480464	CTD
G	PIK3R1	phosphoinositide-3-kinase, regulatory subunit 1 (alpha)		increases expression	ISO	5	67,511,584	67,597,649	RGD:6480464	CTD
G	PIK3R3	phosphoinositide-3-kinase, regulatory subunit 3 (gamma)		increases expression	ISO	1	46,505,812	46,598,708	RGD:6480464	CTD
G	PIR	pirin (iron-binding nuclear protein)		increases expression	EXP	X	15,402,921	15,511,711	RGD:6480464	CTD
G	PLAT	plasminogen activator, tissue		increases expression	EXP	8	42,032,236	42,065,194	RGD:6480464	CTD
G	PPARA	peroxisome proliferator-activated receptor alpha		multiple interactions	EXP	22	46,546,499	46,639,653	RGD:6480464	CTD
G	PPARG	peroxisome proliferator-activated receptor gamma		increases activity	EXP	3	12,329,349	12,475,855	RGD:6480464	CTD
G	PPARG	peroxisome proliferator-activated receptor gamma		multiple interactions	EXP	3	12,329,349	12,475,855	RGD:6480464	CTD
G	PPARG	peroxisome proliferator-activated receptor gamma		multiple interactions	ISO	3	12,329,349	12,475,855	RGD:6480464	CTD
G	PPARG	peroxisome proliferator-activated receptor gamma		multiple interactions	ISO	3	12,329,349	12,475,855	RGD:6480464	CTD
G	PPARG	peroxisome proliferator-activated receptor gamma		multiple interactions	ISO	3	12,329,349	12,475,855	RGD:6480464	CTD
G	PPARG	peroxisome proliferator-activated receptor gamma		multiple interactions	ISO	3	12,329,349	12,475,855	RGD:6480464	CTD
G	PPARGC1A	peroxisome proliferator-activated receptor gamma, coactivator 1 alpha		increases expression	EXP	4	23,793,644	23,891,700	RGD:6480464	CTD
G	PPARGC1A	peroxisome proliferator-activated receptor gamma, coactivator 1 alpha		multiple interactions	ISO	4	23,793,644	23,891,700	RGD:6480464	CTD
G	PPARGC1A	peroxisome proliferator-activated receptor gamma, coactivator 1 alpha		increases expression	ISO	4	23,793,644	23,891,700	RGD:6480464	CTD
G	PRAME	preferentially expressed antigen in melanoma		multiple interactions	EXP	22	22,890,123	22,901,696	RGD:6480464	CTD
G	PSG5	pregnancy specific beta-1-glycoprotein 5		multiple interactions	EXP	19	43,671,895	43,690,688	RGD:6480464	CTD
G	PTEN	phosphatase and tensin homolog		multiple interactions	ISO	10	89,623,195	89,728,532	RGD:6480464	CTD
G	PTGS1	prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)		decreases expression	EXP	9	125,132,809	125,157,982	RGD:6480464	CTD
G	PTGS2	prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)		decreases expression	EXP	1	186,640,944	186,649,559	RGD:6480464	CTD
G	PTHLH	parathyroid hormone-like hormone		decreases expression	EXP	12	28,111,017	28,124,916	RGD:6480464	CTD
G	PTHLH	parathyroid hormone-like hormone		multiple interactions	EXP	12	28,111,017	28,124,916	RGD:6480464	CTD
G	RAB11B	RAB11B, member RAS oncogene family		increases expression	ISO	19	8,455,205	8,469,318	RGD:6480464	CTD
G	RAB27A	RAB27A, member RAS oncogene family		decreases response to substance	EXP	15	55,495,164	55,582,013	RGD:6480464	CTD
G	RAB27A	RAB27A, member RAS oncogene family		decreases expression	EXP	15	55,495,164	55,582,013	RGD:6480464	CTD
G	RARA	retinoic acid receptor, alpha		multiple interactions	EXP	17	38,465,423	38,513,895	RGD:6480464	CTD
G	RARA	retinoic acid receptor, alpha		decreases expression	EXP	17	38,465,423	38,513,895	RGD:6480464	CTD
G	RARA	retinoic acid receptor, alpha		multiple interactions	EXP	17	38,465,423	38,513,895	RGD:6480464	CTD
G	RARA	retinoic acid receptor, alpha		increases expression	ISO	17	38,465,423	38,513,895	RGD:6480464	CTD
G	RARA	retinoic acid receptor, alpha		increases expression	ISO	17	38,465,423	38,513,895	RGD:6480464	CTD
G	RARA	retinoic acid receptor, alpha		increases expression	EXP	17	38,465,423	38,513,895	RGD:6480464	CTD
G	RARA	retinoic acid receptor, alpha		multiple interactions	ISO	17	38,465,423	38,513,895	RGD:6480464	CTD
G	RARA	retinoic acid receptor, alpha		increases expression	EXP	17	38,465,423	38,513,895	RGD:6480464	CTD
G	RARB	retinoic acid receptor, beta		affects binding	EXP	3	25,469,754	25,639,423	RGD:6480464	CTD
G	RARB	retinoic acid receptor, beta		increases expression	EXP	3	25,469,754	25,639,423	RGD:6480464	CTD
G	RARB	retinoic acid receptor, beta		increases expression	EXP	3	25,469,754	25,639,423	RGD:6480464	CTD
G	RARB	retinoic acid receptor, beta		affects binding	ISO	3	25,469,754	25,639,423	RGD:6480464	CTD
G	RARB	retinoic acid receptor, beta		increases expression	ISO	3	25,469,754	25,639,423	RGD:6480464	CTD
G	RARB	retinoic acid receptor, beta		increases expression	ISO	3	25,469,754	25,639,423	RGD:6480464	CTD
G	RARB	retinoic acid receptor, beta		multiple interactions	ISO	3	25,469,754	25,639,423	RGD:6480464	CTD
G	RARG	retinoic acid receptor, gamma		multiple interactions	EXP	12	53,604,350	53,626,040	RGD:6480464	CTD
G	RARG	retinoic acid receptor, gamma		decreases expression	EXP	12	53,604,350	53,626,040	RGD:6480464	CTD
G	RARRES1	retinoic acid receptor responder (tazarotene induced) 1		increases expression	EXP	3	158,414,897	158,450,275	RGD:6480464	CTD
G	RARRES3	retinoic acid receptor responder (tazarotene induced) 3		increases expression	EXP	11	63,304,273	63,313,930	RGD:6480464	CTD
G	RASL11A	RAS-like, family 11, member A		increases expression	ISO	13	27,844,464	27,847,827	RGD:6480464	CTD
G	RB1	retinoblastoma 1		decreases phosphorylation	EXP	13	48,877,883	49,056,026	RGD:6480464	CTD
G	RBP1	retinol binding protein 1, cellular		increases abundance	ISO	3	139,236,276	139,258,671	RGD:6480464	CTD
G	REST	RE1-silencing transcription factor		increases expression	ISO	4	57,774,042	57,802,010	RGD:6480464	CTD
G	RETN	resistin		decreases secretion	ISO	19	7,733,972	7,735,340	RGD:6480464	CTD
G	RETN	resistin		decreases expression	ISO	19	7,733,972	7,735,340	RGD:6480464	CTD
G	RHOA	ras homolog family member A		decreases expression	EXP	3	49,396,578	49,449,526	RGD:6480464	CTD
G	RHOB	ras homolog family member B		decreases expression	EXP	2	20,646,835	20,649,201	RGD:6480464	CTD
G	RNF5	ring finger protein 5, E3 ubiquitin protein ligase		decreases expression	EXP	6	32,146,162	32,148,570	RGD:6480464	CTD
G	RPL22	ribosomal protein L22		increases expression	ISO	1	6,245,080	6,259,679	RGD:6480464	CTD
G	RPS6KA1	ribosomal protein S6 kinase, 90kDa, polypeptide 1		multiple interactions	ISO	1	26,856,249	26,901,520	RGD:6480464	CTD
G	RPS6KB1	ribosomal protein S6 kinase, 70kDa, polypeptide 1		multiple interactions	ISO	17	57,970,443	58,027,787	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		affects localization	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		decreases expression	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		increases degradation	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		increases expression	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		increases ubiquitination	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		affects binding	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	ISO	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		affects binding	ISO	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	ISO	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	ISO	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		increases localization	ISO	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	ISO	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	ISO	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		increases expression	ISO	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		affects binding	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	ISO	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	EXP	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	ISO	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRA	retinoid X receptor, alpha		multiple interactions	ISO	9	137,218,316	137,332,431	RGD:6480464	CTD
G	RXRB	retinoid X receptor, beta		multiple interactions	EXP	6	33,161,362	33,168,473	RGD:6480464	CTD
G	RXRB	retinoid X receptor, beta		affects binding	EXP	6	33,161,362	33,168,473	RGD:6480464	CTD
G	RXRB	retinoid X receptor, beta		multiple interactions	EXP	6	33,161,362	33,168,473	RGD:6480464	CTD
G	RXRB	retinoid X receptor, beta		increases degradation	EXP	6	33,161,362	33,168,473	RGD:6480464	CTD
G	RXRB	retinoid X receptor, beta		increases activity	EXP	6	33,161,362	33,168,473	RGD:6480464	CTD
G	RXRB	retinoid X receptor, beta		increases expression	ISO	6	33,161,362	33,168,473	RGD:6480464	CTD
G	RXRB	retinoid X receptor, beta		multiple interactions	EXP	6	33,161,362	33,168,473	RGD:6480464	CTD
G	RXRG	retinoid X receptor, gamma		decreases expression	EXP	1	165,370,159	165,414,592	RGD:6480464	CTD
G	RXRG	retinoid X receptor, gamma		multiple interactions	EXP	1	165,370,159	165,414,592	RGD:6480464	CTD
G	RXRG	retinoid X receptor, gamma		affects activity	ISO	1	165,370,159	165,414,592	RGD:6480464	CTD
G	RXRG	retinoid X receptor, gamma		decreases expression	ISO	1	165,370,159	165,414,592	RGD:6480464	CTD
G	RXRG	retinoid X receptor, gamma		increases expression	ISO	1	165,370,159	165,414,592	RGD:6480464	CTD
G	RXRG	retinoid X receptor, gamma		decreases expression	ISO	1	165,370,159	165,414,592	RGD:6480464	CTD
G	S100A1	S100 calcium binding protein A1		decreases expression	EXP	1	153,600,873	153,604,512	RGD:6480464	CTD
G	S100A7	S100 calcium binding protein A7		increases expression	EXP	1	153,430,220	153,433,137	RGD:6480464	CTD
G	S100A8	S100 calcium binding protein A8		decreases expression	EXP	1	153,362,508	153,363,664	RGD:6480464	CTD
G	S100A9	S100 calcium binding protein A9		increases expression	EXP	1	153,330,330	153,333,503	RGD:6480464	CTD
G	SAA2	serum amyloid A2		increases expression	ISO	11	18,259,780	18,270,221	RGD:6480464	CTD
G	SCARB1	scavenger receptor class B, member 1		increases expression	EXP	12	125,262,174	125,348,519	RGD:6480464	CTD
G	SEMA6B	sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B		multiple interactions	EXP	19	4,542,600	4,559,771	RGD:6480464	CTD
G	SERPINA3	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3		increases expression	EXP	14	95,078,714	95,090,390	RGD:6480464	CTD
G	SERPINB2	serpin peptidase inhibitor, clade B (ovalbumin), member 2		decreases expression	EXP	18	61,554,939	61,571,124	RGD:6480464	CTD
G	SERPINB8	serpin peptidase inhibitor, clade B (ovalbumin), member 8		decreases expression	EXP	18	61,637,263	61,656,608	RGD:6480464	CTD
G	SERPINB9	serpin peptidase inhibitor, clade B (ovalbumin), member 9		decreases expression	EXP	6	2,887,499	2,903,546	RGD:6480464	CTD
G	SERPINE1	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1		multiple interactions	EXP	7	100,770,370	100,782,547	RGD:6480464	CTD
G	SLC16A1	solute carrier family 16, member 1 (monocarboxylic acid transporter 1)		decreases expression	EXP	1	113,454,469	113,498,975	RGD:6480464	CTD
G	SLC2A2	solute carrier family 2 (facilitated glucose transporter), member 2		decreases expression	ISO	3	170,714,137	170,744,768	RGD:6480464	CTD
G	SLC2A2	solute carrier family 2 (facilitated glucose transporter), member 2		decreases activity	ISO	3	170,714,137	170,744,768	RGD:6480464	CTD
G	SLC2A2	solute carrier family 2 (facilitated glucose transporter), member 2		decreases activity	ISO	3	170,714,137	170,744,768	RGD:6480464	CTD
G	SLC2A4	solute carrier family 2 (facilitated glucose transporter), member 4		increases expression	ISO	17	7,185,054	7,191,367	RGD:6480464	CTD
G	SLC2A4	solute carrier family 2 (facilitated glucose transporter), member 4		increases expression	ISO	17	7,185,054	7,191,367	RGD:6480464	CTD
G	SLC2A4	solute carrier family 2 (facilitated glucose transporter), member 4		increases expression	ISO	17	7,185,054	7,191,367	RGD:6480464	CTD
G	SLC5A5	solute carrier family 5 (sodium iodide symporter), member 5		increases expression	EXP	19	17,982,782	18,005,983	RGD:6480464	CTD
G	SMAD3	SMAD family member 3		multiple interactions	ISO	15	67,358,195	67,487,533	RGD:6480464	CTD
G	SNN	stannin		decreases expression	ISO	16	11,762,289	11,773,015	RGD:6480464	CTD
G	SOCS1	suppressor of cytokine signaling 1		decreases expression	EXP	16	11,348,274	11,350,039	RGD:6480464	CTD
G	SOCS2	suppressor of cytokine signaling 2		increases expression	EXP	12	93,963,598	93,970,521	RGD:6480464	CTD
G	SPINK1	serine peptidase inhibitor, Kazal type 1		increases expression	ISO	5	147,204,143	147,211,260	RGD:6480464	CTD
G	SPP1	secreted phosphoprotein 1		decreases expression	EXP	4	88,896,802	88,904,563	RGD:6480464	CTD
G	SPP1	secreted phosphoprotein 1		increases expression	ISO	4	88,896,802	88,904,563	RGD:6480464	CTD
G	SPP1	secreted phosphoprotein 1		decreases expression	ISO	4	88,896,802	88,904,563	RGD:6480464	CTD
G	SPRR1B	small proline-rich protein 1B		decreases expression	EXP	1	153,003,679	153,005,376	RGD:6480464	CTD
G	STAT1	signal transducer and activator of transcription 1, 91kDa		multiple interactions	EXP	2	191,833,762	191,878,976	RGD:6480464	CTD
G	STAT1	signal transducer and activator of transcription 1, 91kDa		multiple interactions	EXP	2	191,833,762	191,878,976	RGD:6480464	CTD
G	STS	steroid sulfatase (microsomal), isozyme S		increases activity	EXP	X	7,137,472	7,272,682	RGD:6480464	CTD
G	SULT2A1	sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1		decreases expression	EXP	19	48,373,723	48,389,654	RGD:6480464	CTD
G	TACSTD2	tumor-associated calcium signal transducer 2		increases expression	EXP	1	59,041,095	59,043,166	RGD:6480464	CTD
G	TBC1D4	TBC1 domain family, member 4		increases phosphorylation	ISO	13	75,858,809	76,056,250	RGD:6480464	CTD
G	TBC1D4	TBC1 domain family, member 4		multiple interactions	ISO	13	75,858,809	76,056,250	RGD:6480464	CTD
G	TERT	telomerase reverse transcriptase		decreases expression	ISO	5	1,253,282	1,295,162	RGD:6480464	CTD
G	TGFB1	transforming growth factor, beta 1		decreases response to substance	ISO	19	41,836,812	41,859,831	RGD:6480464	CTD
G	TGFB1	transforming growth factor, beta 1		multiple interactions	EXP	19	41,836,812	41,859,831	RGD:6480464	CTD
G	TGFB1	transforming growth factor, beta 1		decreases activity	EXP	19	41,836,812	41,859,831	RGD:6480464	CTD
G	TGFB1	transforming growth factor, beta 1		multiple interactions	ISO	19	41,836,812	41,859,831	RGD:6480464	CTD
G	TGFB1	transforming growth factor, beta 1		decreases expression	ISO	19	41,836,812	41,859,831	RGD:6480464	CTD
G	TGFB1I1	transforming growth factor beta 1 induced transcript 1		increases expression	EXP	16	31,483,476	31,489,281	RGD:6480464	CTD
G	TGIF1	TGFB-induced factor homeobox 1		increases expression	EXP	18	3,412,072	3,458,409	RGD:6480464	CTD
G	TGIF1	TGFB-induced factor homeobox 1		multiple interactions	ISO	18	3,412,072	3,458,409	RGD:6480464	CTD
G	TGM1	transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase)		decreases expression	EXP	14	24,718,320	24,732,416	RGD:6480464	CTD
G	TGM2	transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)		multiple interactions	EXP	20	36,756,863	36,793,700	RGD:6480464	CTD
G	TGM2	transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)		increases activity	EXP	20	36,756,863	36,793,700	RGD:6480464	CTD
G	TGM2	transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)		increases expression	EXP	20	36,756,863	36,793,700	RGD:6480464	CTD
G	TGM2	transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)		increases expression	EXP	20	36,756,863	36,793,700	RGD:6480464	CTD
G	TGM2	transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)		increases expression	EXP	20	36,756,863	36,793,700	RGD:6480464	CTD
G	TGM2	transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)		increases expression	EXP	20	36,756,863	36,793,700	RGD:6480464	CTD
G	TGM2	transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)		increases expression	EXP	20	36,756,863	36,793,700	RGD:6480464	CTD
G	THBS1	thrombospondin 1		decreases expression	EXP	15	39,873,280	39,889,668	RGD:6480464	CTD
G	TNF	tumor necrosis factor		decreases expression	EXP	6	31,543,344	31,546,113	RGD:6480464	CTD
G	TNF	tumor necrosis factor		multiple interactions	ISO	6	31,543,344	31,546,113	RGD:6480464	CTD
G	TNF	tumor necrosis factor		multiple interactions	ISO	6	31,543,344	31,546,113	RGD:6480464	CTD
G	TNFRSF10A	tumor necrosis factor receptor superfamily, member 10a		increases expression	EXP	8	23,048,970	23,082,680	RGD:6480464	CTD
G	TNFRSF10B	tumor necrosis factor receptor superfamily, member 10b		increases expression	EXP	8	22,877,646	22,926,700	RGD:6480464	CTD
G	TNFSF10	tumor necrosis factor (ligand) superfamily, member 10		increases expression	EXP	3	172,223,298	172,241,297	RGD:6480464	CTD
G	TSHB	thyroid stimulating hormone, beta		decreases expression	ISO	1	115,572,415	115,576,941	RGD:6480464	CTD
G	TSHB	thyroid stimulating hormone, beta		decreases expression	ISO	1	115,572,415	115,576,941	RGD:6480464	CTD
G	TSHB	thyroid stimulating hormone, beta		decreases expression	ISO	1	115,572,415	115,576,941	RGD:6480464	CTD
G	TTR	transthyretin		decreases expression	ISO	18	29,171,730	29,178,987	RGD:6480464	CTD
G	TUBA1A	tubulin, alpha 1a		increases expression	ISO	12	49,578,578	49,583,107	RGD:6480464	CTD
G	UCP1	uncoupling protein 1 (mitochondrial, proton carrier)		increases expression	ISO	4	141,481,050	141,489,959	RGD:6480464	CTD
G	UCP1	uncoupling protein 1 (mitochondrial, proton carrier)		multiple interactions	ISO	4	141,481,050	141,489,959	RGD:6480464	CTD
G	UCP1	uncoupling protein 1 (mitochondrial, proton carrier)		increases expression	ISO	4	141,481,050	141,489,959	RGD:6480464	CTD
G	UGDH	UDP-glucose 6-dehydrogenase		multiple interactions	EXP	4	39,500,375	39,529,218	RGD:6480464	CTD
G	UGT1A1	UDP glucuronosyltransferase 1 family, polypeptide A1		increases expression	ISO	2	234,668,919	234,681,945	RGD:6480464	CTD
G	UGT1A3	UDP glucuronosyltransferase 1 family, polypeptide A3		increases expression	ISO	2	234,637,773	234,681,945	RGD:6480464	CTD
G	UGT1A5	UDP glucuronosyltransferase 1 family, polypeptide A5		increases expression	ISO	2	234,621,638	234,681,945	RGD:6480464	CTD
G	UGT1A6	UDP glucuronosyltransferase 1 family, polypeptide A6		decreases expression	ISO	2	234,600,321	234,681,951	RGD:6480464	CTD
G	UVRAG	UV radiation resistance associated		decreases expression	EXP	11	75,526,212	75,855,282	RGD:6480464	CTD
G	VDR	vitamin D (1,25- dihydroxyvitamin D3) receptor		multiple interactions	EXP	12	48,235,320	48,298,814	RGD:6480464	CTD
G	VDR	vitamin D (1,25- dihydroxyvitamin D3) receptor		increases degradation	EXP	12	48,235,320	48,298,814	RGD:6480464	CTD
G	VDR	vitamin D (1,25- dihydroxyvitamin D3) receptor		multiple interactions	EXP	12	48,235,320	48,298,814	RGD:6480464	CTD
G	VDR	vitamin D (1,25- dihydroxyvitamin D3) receptor		affects activity	EXP	12	48,235,320	48,298,814	RGD:6480464	CTD
G	VEGFA	vascular endothelial growth factor A		increases expression	EXP	6	43,737,946	43,754,224	RGD:6480464	CTD
G	VEGFC	vascular endothelial growth factor C		decreases expression	EXP	4	177,604,691	177,713,895	RGD:6480464	CTD
G	WNT5B	wingless-type MMTV integration site family, member 5B		decreases expression	EXP	12	1,726,222	1,756,378	RGD:6480464	CTD

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	513708
role	503229
biological role	501402
biochemical role	202578
metabolite	183244
9-cis-retinoic acid	467
9-cis-4-hydroxyretinoic acid	0
Path 2
Term	Annotations
CHEBI ontology	513708
subatomic particle	512601
composite particle	512601
hadron	512601
baryon	512601
nucleon	512601
atomic nucleus	512601
atom	512601
main group element atom	480609
p-block element atom	478027
carbon group element atom	427614
carbon atom	424022
organic molecular entity	424015
organic group	174681
organic divalent group	173480
organodiyl group	173480
carbonyl group	173163
carbonyl compound	173163
carboxylic acid	126604
monocarboxylic acid	73216
retinoic acid	8715
9-cis-retinoic acid	467
9-cis-4-hydroxyretinoic acid	0